Works matching IS 10837159 AND DT 2025 AND VI 30 AND IP 1

Results: 32

Is it time to retire preoperative radiation for localized esophageal and gastro-esophageal adenocarcinoma?

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae371

By:

Pabon, Cindy M;
Spieler, Benjamin;
Li, Jenny J;
Ajani, Jaffer;
Hosein, Peter J;
Murphy, Mariela Blum

Publication type:

Article

Liver transplantation for colorectal cancer with liver metastases.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae367

By:

Ueberroth, Benjamin E;
Kriss, Michael;
Burton, James R;
Messersmith, Wells A

Publication type:

Article

The Oncologist turns thirty.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae365

By:

Bates, Susan E

Publication type:

Article

A phase II study of ramucirumab and somatostatin analog therapy in patients with advanced neuroendocrine tumors.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae364

By:

Perez, Kimberly;
Kulke, Matthew H;
Zheng, Hui;
Allen, Jill;
Clark, Jeffrey;
Enzinger, Andrea C;
Enzinger, Peter C;
Johnson, Bruce E;
McCleary, Nadine J;
Parikh, Aparna;
Patel, Anuj;
Rubinson, Douglas;
Yurgelun, Matthew B;
Ramsey, Kaitlyn;
Johnson, Emma;
Graham, Christopher;
Chan, Jennifer A

Publication type:

Article

Correction to: Clinical and economic impact of pharmacist interventions to identify drug-related problems in multidisciplinary cancer care: a prospective trial.

Published in:: 2025
Publication type:: Correction Notice

Steroid-refractory immune mediated hepatitis managed with budesonide in patients with metastatic melanoma: proof of concept and literature review.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae361

By:

Kankaria, Roma A;
Johnson, Douglas B

Publication type:

Article

Radiotherapy and surgery: can this combination be further optimized for patients with metastatic spine disease?

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae359

By:

Amelink, Jantijn J G J;
Bindels, Bas J J;
Kasperts, Nicolien;
MacDonald, Shannon M;
Tobert, Daniel G;
Verlaan, Jorrit-Jan

Publication type:

Article

Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancer.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae356

By:

Skoulidis, Ferdinandos;
Li, Bob T;
Hochmair, Maximilian;
Govindan, Ramaswamy;
Vincent, Mark;
Wekken, Anthonie J van der;
Aransay, Noemi Reguart;
O'Byrne, Kenneth J;
Girard, Nicolas;
Griesinger, Frank;
Nishio, Makoto;
Häfliger, Simon;
Lindsay, Colin;
Reinmuth, Niels;
Paulus, Astrid;
Papakotoulas, Pavlos;
Kim, Sang-We;
Ferreira, Carlos Gil;
Pasello, Giulia;
Duruisseaux, Michael

Publication type:

Article

Correction to: Quality of life in women with early-stage and metastatic hormone receptor-positive, HER2-negative breast cancer receiving endocrine therapy.

Published in:: 2025
Publication type:: Correction Notice

Machine learning models for predicting postoperative peritoneal metastasis after hepatocellular carcinoma rupture: a multicenter cohort study in China.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae341

By:

Xia, Feng;
Chen, Qian;
Liu, Zhicheng;
Zhang, Qiao;
Guo, Bin;
Fan, Feimu;
Huang, Zhiyuan;
Zheng, Jun;
Gao, Hengyi;
Xia, Guobing;
Ren, Li;
Mei, Hongliang;
Chen, Xiaoping;
Cheng, Qi;
Zhang, Bixiang;
Zhu, Peng

Publication type:

Article

Precision medicine: an intrahepatic cholangiocarcinoma with a novel RBPMS-MET fusion sensitive to crizotinib.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae340

By:

Wan, Wei;
Liu, Xueqin;
Zhang, Yamin;
Shen, Rui;
Xia, Weihu;
Li, Shuangni;
Tan, Yuan;
Duan, Qianqian;
Liu, Jinpeng;
Wang, Wuping

Publication type:

Article

Ovarian clear cell carcinoma: open questions on the management and treatment algorithm.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae325

By:

Rosso, Roberta;
Turinetto, Margherita;
Borella, Fulvio;
Chopin, Nicolas;
Meeus, Pierre;
Lainè, Alexandra;
Ray-Coquard, Isabelle;
Saux, Olivia Le;
Ferraioli, Domenico

Publication type:

Article

Pembrolizumab ± paricalcitol in metastatic pancreatic cancer postmaximal cytoreduction.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae323

By:

Chung, Vincent;
Alistar, Angela;
Becerra, Carlos;
Kasi, Anup;
Borazanci, Erkut;
Jameson, Gayle S;
Roe, Denise J;
Wertheim, Betsy C;
Cridebring, Derek;
Truitt, Morgan;
Downes, Michael;
Barrett, Michael T;
Korn, Ron;
Lee, Keehoon;
Han, Haiyong;
Evans, Ronald;
Hoff, Daniel D Von

Publication type:

Article

A first-in-human study of JNJ-70218902, a bispecific T-cell-redirecting antibody against TMEFF2 in metastatic castration-resistant prostate cancer.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae313

By:

Calvo, Emiliano;
Doger, Bernard;
Carles, Joan;
Peer, Avivit;
Sarid, David;
Eigl, Bernhard J;
Avadhani, Anjali;
Yao, David;
Lin, Vincent;
Wu, Shujian;
Jaiprasart, Pharavee;
Loffredo, John;
Tamegnon, Monelle;
Xu, Weichun;
Xie, Hong;
Hansen, Aaron R

Publication type:

Article

Feasibility and acceptability of a mindfulness app-based intervention among patients with metastatic renal cell carcinoma: a multinational study.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae309

By:

Bergerot, Cristiane Decat;
Bergerot, Paulo Gustavo;
Philip, Errol J;
Malhotra, Jasnoor;
Castro, Daniela V;
Govindarajan, Ameish;
Fuzita, William Hiromi;
França, Marcos Vinicius da Silva;
Azeredo, Andressa Cardoso de;
Anjos, Gabriel Marques dos;
Araujo, Romildo de;
Hsu, JoAnn;
Chawla, Neal;
Chehrazi-Raffle, Alex;
Buso, Marco Murilo;
Saab, Bechara;
Carlson, Linda E;
Pal, Sumanta K

Publication type:

Article

Next-generation sequencing-based evaluation of the actionable landscape of genomic alterations in solid tumors: the "MOZART" prospective observational study.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae206

By:

Schettini, Francesco;
Sirico, Marianna;
Loddo, Marco;
Williams, Gareth H;
Hardisty, Keeda-Marie;
Scorer, Paul;
Thatcher, Robert;
Rivera, Pablo;
Milani, Manuela;
Strina, Carla;
Ferrero, Giuseppina;
Ungari, Marco;
Bottin, Cristina;
Zanconati, Fabrizio;
Manzini, Nicolò de;
Aguggini, Sergio;
Tancredi, Richard;
Fiorio, Elena;
Fioravanti, Antonio;
Scaltriti, Maurizio

Publication type:

Article

Real-world use of pemigatinib for the treatment of cholangiocarcinoma in the US.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae204

By:

Saverno, Kim;
Savill, Kristin M Zimmerman;
Brown-Bickerstaff, Cherrishe;
Kotomale, Angele;
Rodriguez, Michael;
Feinberg, Bruce;
Ren, Haobo;
Blecker, Mike;
Kim, Richard

Publication type:

Article

Phase I study of intratumoral injection of talimogene laherparepvec for the treatment of advanced pancreatic cancer.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae200

By:

Runcie, Karie;
Bracero, Yadriel;
Samouha, Avishai;
Manji, Gulam;
Remotti, Helen E;
Gonda, Tamas A;
Saenger, Yvonne

Publication type:

Article

Immune checkpoint inhibitor infusion times and clinical outcomes in patients with melanoma.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae197

By:

Fletcher, Kylie;
Rehman, Saba;
Irlmeier, Rebecca;
Ye, Fei;
Johnson, Douglas

Publication type:

Article

Pegylated liposomal doxorubicin in partially platinum-sensitive, platinum-resistant, or platinum-refractory ovarian cancer: a prospective study.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae194

By:

Zhang, Ying;
Yuan, Zhen;
Zhang, Guo-Nan;
Li, Qing-Shui;
Cui, Man-Hua;
Cheng, Wen-Jun;
Meng, Yuan-Guang;
Wu, Xiao-Hua;
Yue, Ying;
Wang, Li;
Hou, Jian-Qing;
Li, Chang-Zhong;
Qu, Peng-Peng;
Sun, Li-Xin;
Tao, Guang-Shi;
Li, Gui-Ling;
Chen, Ya-Qing;
Ren, Fang;
Cao, Dong-Yan;
Shen, Keng

Publication type:

Article

Impact of HER2-targeted PET/CT imaging in patients with breast cancer and therapeutic response monitoring.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae188

By:

Gui, Xinyu;
Liang, Xu;
Guo, Xiaoyi;
Yang, Zhi;
Song, Guohong

Publication type:

Article

Molecular tumor board: molecularly adjusted therapy upon identification and functional validation of a novel ALK resistance mutation in a case of lung adenocarcinoma.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae143

By:

Arndt, Annette;
Neumann, Christian;
Riecke, Armin;
Bauer, Arthur;
Müller, Matthias;
Wölfle-Guter, Manuela;
Grunert, Michael;
Busch, Hauke;
Künstner, Axel;
Bubnoff, Nikolas von;
Fliedner, Stephanie;
Greinert, Dina;
Osius, Jasmin;
Nagarathinam, Kumar;
Steinestel, Konrad;
Gorantla, Sivahari Prasad;
Gebauer, Niklas;
Witte, Hanno M

Publication type:

Article

Treatment patterns for patients with BRCA1/2-positive metastatic castration-resistant prostate cancer.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae183

By:

Bilen, Mehmet A;
Khilfeh, Ibrahim;
Rossi, Carmine;
Morrison, Laura;
Diaz, Lilian;
Hilts, Annalise;
Lefebvre, Patrick;
Pilon, Dominic;
George, Daniel J

Publication type:

Article

Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae182

By:

Yousef, Mahmoud;
Hurd, Mark W;
Yousef, Abdelrahman;
Ludmir, Ethan B;
Pillai, Ashwathy B;
Peterson, Jennifer;
Koay, Eugene J;
Albarouki, Sali;
Tzeng, Ching-Wei;
Snyder, Rebecca;
Katz, Matthew H G;
Wang, Huamin;
Overman, Michael J;
Maitra, Anirban;
Pant, Shubham;
Smaglo, Brandon G;
Wolff, Robert A;
Yao, James;
Shen, John P;
Zhao, Dan

Publication type:

Article

Dramatic response to crizotinib through MET phosphorylation inhibition in rare TFG-MET fusion advanced squamous cell lung cancer.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae166

By:

Cheng, Wanwan;
Xu, Ting;
Yang, Lu;
Yan, Naimeng;
Yang, Jie;
Fang, Shencun

Publication type:

Article

Novel anti-HER2 ADCs vs dual anti-HER2 antibody for HER2-positive metastatic breast cancer failed to tyrosine kinase inhibitor.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae144

By:

Li, Feng;
Li, Jianbin;
Ji, Chenchen;
Wu, Song;
Zhang, Shaohua;
Wang, Tao;
Bian, Li;
Jiang, Zefei

Publication type:

Article

Immune-related encephalitis after immune checkpoint inhibitor therapy.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae186

By:

Buckley, Monica W;
Warner, Aanika Balaji;
Brahmer, Julie;
Cappelli, Laura C;
Sharfman, William H;
Fuchs, Ephraim;
Kang, Hyunseok;
Forde, Patrick M;
Gladstone, Douglas E;
Ambinder, Richard;
Kelly, Ronan J;
Lipson, Evan J;
Gojo, Ivana;
Lee, Edward J;
Johnson, Tory P;
Saidha, Shiv;
Llinas, Rafael;
Ostrow, Lyle W;
Naidoo, Jarushka;
Probasco, John C

Publication type:

Article

Oncofusions – shaping cancer care.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae126

By:

Dashi, Giovanna;
Varjosalo, Markku

Publication type:

Article

Prolonged complete response to adjuvant tepotinib in a patient with newly diagnosed disseminated glioblastoma harboring mesenchymal-epithelial transition fusion.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae100

By:

Pham, Lily C;
Weller, Lauryn;
Gann, Claudia N;
Schumacher, Karl Maria;
Vlassak, Soetkin;
Swanson, Todd;
Highsmith, Kaitlin;
O'Brien, Barbara J;
Nash, Sebnem;
Aaroe, Ashley;
Groot, John F de;
Majd, Nazanin K

Publication type:

Article

Association of opioid use with survival in patients with cancer treated with immune checkpoint inhibitors: it is time for evidence-based behaviors.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae081

By:

Giusti, Raffaele;
Porzio, Giampiero;
Maltoni, Marco;
Filetti, Marco;
Cuomo, Arturo;
Bandieri, Elena;
Trapani, Dario;
Bruera, Eduardo

Publication type:

Article

Primary Resistance to RET Inhibition in a RET Fusion-Positive Pancreatic Neuroendocrine Carcinoma.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae034

By:

McKinley, Blake J;
Coston, Tucker W;
Starr, Jason S

Publication type:

Article

Anaplastic Lymphoma Kinase (ALK) Inhibitors Show Activity in Colorectal Cancer With ALK Rearrangements: Case Series and Literature Review.

Published in:

Oncologist, 2025, v. 30, n. 1, p. 1, doi. 10.1093/oncolo/oyae020

By:

Hu, Tingting;
Zhan, Jinbo;
Li, Li;
He, Yan;
Lin, Yun;
Wang, Jingru;
Yu, Haiming;
Xiong, Jianping;
Fang, Ziling;
Deng, Jun;
Huang, Shanshan;
Xiang, Xiaojun

Publication type:

Article